The Promise of Biosimilar Drugs

The Promise of Biosimilar Drugs

In 2006, the European Medicines Agency granted its first approval of a biosimilar drug, the human growth hormone, Omnitrope™ (Sandoz), and opened the doors of opportunity for this emerging field of medicine. In 2010, President Obama signed into law the Biosimilars...
Biorasi is Your Preferred Provider

Biorasi is Your Preferred Provider

Biorasi has been engineered internally to deliver sponsor partners optimal clinical trial results, especially, for Biosimilar Studies. We understand the importance of strong, dependable relationships and pride ourselves on being the support for our clients. You gain a...